We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

336 hedge funds and large institutions have $14.3B invested in PHARMACYCLICS INC in 2015 Q1 according to their latest regulatory filings, with 124 funds opening new positions, 80 increasing their positions, 107 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

413% more funds holding in top 10

Funds holding in top 10: 841 (+33)

97% more capital invested

Capital invested by funds: $7.27B → $14.3B (+$7.07B)

82% more first-time investments, than exits

New positions opened: 124 | Existing positions closed: 68

34% more call options, than puts

Call options by funds: $1.1B | Put options by funds: $823M

20% more funds holding

Funds holding: 281336 (+55)

25% less repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 107

Holders
336
Holders Change
+55
Holders Change %
+19.57%
% of All Funds
8.95%
Holding in Top 10
41
Holding in Top 10 Change
+33
Holding in Top 10 Change %
+412.5%
% of All Funds
1.09%
New
124
Increased
80
Reduced
107
Closed
68
Calls
$1.1B
Puts
$823M
Net Calls
+$276M
Net Calls Change
+$309M
Name Holding Trade Value Shares
Change
Change in
Stake
AB
201
Amalgamated Bank
New York
$1.76M +$45.9K +238 +4%
LS
202
Livforsakringsbolaget Skandia
Sweden
$1.75M -$425K -2,200 -24%
KM
203
KS Management
New York
$1.74M +$1.31M +6,800 New
NMIMC
204
Northwestern Mutual Investment Management Company
Wisconsin
$1.73M +$1.3M +6,740 New
AAF
205
Andra AP-fonden
Sweden
$1.72M +$734K +3,800 +131%
AAM
206
Advisors Asset Management
Colorado
$1.64M +$265K +1,373 +27%
VIA
207
Vident Investment Advisory
Georgia
$1.64M +$1.24M +6,403 New
Nomura Asset Management
208
Nomura Asset Management
Japan
$1.63M -$913K -4,730 -43%
HHC
209
Hutchin Hill Capital
New York
$1.62M +$352K +1,821 +40%
TI
210
TT International
United Kingdom
$1.53M +$1.16M +6,001 New
M&T Bank
211
M&T Bank
New York
$1.51M -$57K -295 -5%
SAM
212
Shell Asset Management
Netherlands
$1.44M -$594K -3,078 -35%
CA
213
Commerzbank Aktiengesellschaft
Germany
$1.35M -$3.66M -18,947 -78%
SG Americas Securities
214
SG Americas Securities
New York
$1.31M -$3.45M -17,878 -78%
New York State Common Retirement Fund
215
New York State Common Retirement Fund
New York
$1.28M -$712K -3,686 -42%
FANJ
216
Financial Architects (New Jersey)
New Jersey
$1.28M
LOAMU
217
Lombard Odier Asset Management (USA)
New York
$1.28M +$965K +5,000 New
AL
218
Airain Ltd
Guernsey
$1.26M -$10.4M -53,857 -92%
WRBC
219
W.R. Berkley Corp
Connecticut
$1.23M +$925K +4,793 New
NG
220
NatWest Group
United Kingdom
$1.2M -$96.5K -500 -10%
SMDAM
221
Sumitomo Mitsui DS Asset Management
Japan
$1.2M -$72.6K -376 -7%
FWCM
222
First Western Capital Management
California
$1.19M -$1.36M -7,055 -60%
OAM
223
Orinda Asset Management
California
$1.15M +$869K +4,500 New
AG
224
Aperio Group
California
$1.15M +$170K +878 +24%
WBC
225
Westpac Banking Corp
Australia
$1.11M -$10.8M -56,141 -94%

PCYC Hedge Fund Activity: Q1 2015 in Review

336 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q1 2015, worth a combined $14.3B — up 97% from $7.27B a quarter earlier.

Buyers outnumbered sellers: 124 funds opened new PCYC positions and 68 closed out — a net gain of 56 holders — while 80 added to existing stakes and 107 trimmed.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $431M. The largest seller was Ameriprise, cutting an estimated $951M.

  • 336 institutional investors held PHARMACYCLICS INC (PCYC) as of Q1 2015, up from 281 in Q4 2014.
  • Funds reported $14.3B of PHARMACYCLICS INC stock for Q1 2015, up 97% quarter-over-quarter.
  • 124 funds opened new PHARMACYCLICS INC positions in Q1 2015 and 68 closed out, a net change of +56 holders.
  • The largest PHARMACYCLICS INC buyer in Q1 2015 was Pentwater Capital Management, an estimated $431M added.
  • The largest PHARMACYCLICS INC seller in Q1 2015 was Ameriprise, an estimated $951M sold.

Based on aggregated 13F filings for Q1 2015.